Offer - Urjas Oil for just ₹ 1 X
Gliclapack M is a prescription drug, available for use as Tablet. Diabetes are some of its major therapeutic uses. Other than this, Gliclapack M has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Gliclapack M is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
The most common side effects of Gliclapack M are Nausea or vomiting, Bradycardia, Constipation. Apart from the aforementioned side effects, Gliclapack M can also lead to other problems, which have been listed below. Such side effects of Gliclapack M normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Gliclapack M's effect is Moderate during pregnancy and Safe for lactating mothers. It is important to know if Gliclapack M has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Gliclapack M related warnings section.
The section on Gliclapack M contraindications lists all such conditions.
Drug reaction of Gliclapack M with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Gliclapack M is considered safe while driving, and is addictive.
Gliclapack M is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Gliclapack M safe for pregnant women?
Gliclapack M can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Gliclapack M right away. Take your doctor's advice before taking it again.
Is the use of Gliclapack M safe during breastfeeding?
Gliclapack M is safe for breastfeeding women.
What is the effect of Gliclapack M on the Kidneys?
Gliclapack M may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Gliclapack M on the Liver?
The liver can be affected by Gliclapack M. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Gliclapack M only after medical advice.
What is the effect of Gliclapack M on the Heart?
Use of Gliclapack M may be dangerous for the heart. Do not use it without doctor's advice.
Gliclapack M should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Gliclapack M unless your doctor advises you to do so -
Is this Gliclapack M habit forming or addictive?
Forming a habit of Gliclapack M has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Gliclapack M as it does not make you drowsy.
Is it safe?
Gliclapack M is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Gliclapack M for mental disorders.
Interaction between Food and Gliclapack M
Taking Gliclapack M with food is safe.
Interaction between Alcohol and Gliclapack M
Taking alcohol with Gliclapack M can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1314-1315
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826